STOCK TITAN

Virax Biolabs Group Limited (VRAX) Revenue by Year

VRAX

Virax Biolabs Group Limited generated $12K in revenue in fiscal year 2026. This represents an increase of 96.2% from the prior fiscal year. The table below carries 6 fiscal years, from 2021 to 2026, and the quarters Virax Biolabs Group Limited has filed alongside them.

FY2026 annual
Revenue $12K
YoY +96.2%
5Y CAGR -36.9%
Source SEC Filings (10-K/10-Q) Latest period FY2026, ended Jul 2, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

VRAX Revenue by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2620-FFY2520-FFY2420-FFY2320-FFY2210-KFY2110-K
Revenue$12K+96.2%$6K-96.0%$156K+1727.1%$9K$0-100.0%$124K

VRAX Revenue by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ3'2520-FQ3'2420-FQ3'2310-KQ3'2210-QQ3'2110-K
RevenueN/AN/AN/AN/AN/A

What revenue means

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.

More Virax Biolabs Group Limited financials

Frequently Asked Questions

What was Virax Biolabs Group Limited's revenue in fiscal year 2026?

Virax Biolabs Group Limited generated $12K in revenue in fiscal year 2026.

How fast is Virax Biolabs Group Limited's revenue growing?

Virax Biolabs Group Limited (VRAX) revenue rose by 96.2% year over year, from $6K to $12K in fiscal year 2026.

How has Virax Biolabs Group Limited's revenue changed over the years?

Across the 6 fiscal years this page covers, Virax Biolabs Group Limited (VRAX) revenue went from $124K in fiscal year 2021 to $12K in fiscal year 2026.

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what Virax Biolabs Group Limited (VRAX) reported on that line in every period on record.